Nanhai Longtime Pharmaceutical Co., Ltd.

rh-bFGF is a national Class I new drug and one of the nine genetic engineering products with independent intellectual property rights,  key research projects of national eighth five-year, ninth five-year plan and key achievements of  863 plan.

Induce stem cell  differentiation and promote cells (from the mesoderm and ectoderm) differentiation and proliferation (such as epithelial cells, endothelial cells, fibroblasts, vascular smooth muscle cells, nervous cells, cartilage cells, osteoblasts, connective tissue cells, etc.); Promote tissue repair, bone growth, new blood vessel formation and nerve regeneration; Promote wound healing, take positively repair all kinds of fresh wounds, chronic wounds and shorten about 30% of healing time; Adjust the balance of collagen in two directions, inhibit scar formation and reduce about 70% of the scar’s height; Recovery the function of movement, perception, hair growth, perspiration,etc.,  so as to reduce wound sequela.